Glucagon-like peptide-1 (7–36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium

[1]  F. C. White,et al.  Coronary collateral circulation in the pig: correlation of collateral flow with coronary bed size , 1981, Basic Research in Cardiology.

[2]  P. Whittaker.  An alternative perspective on ischemic preconditioning derived from mathematical modeling , 1996, Basic Research in Cardiology.

[3]  I. Valverde,et al.  Potent glycogenic effect of GLP-1(7–36)amide in rat skeletal muscle , 1994, Diabetologia.

[4]  C. Saper,et al.  Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. , 2002, The Journal of clinical investigation.

[5]  I. Valverde,et al.  Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes. , 2002, The Journal of endocrinology.

[6]  G. Ronquist,et al.  Pre-conditioning activates adenosine utilization in a cost-effective way during myocardial ischaemia. , 2001, Acta physiologica Scandinavica.

[7]  S. Sollott,et al.  Glucagon-Like Peptide-1 Increases cAMP but Fails to Augment Contraction in Adult Rat Cardiac Myocytes , 2001, Circulation research.

[8]  G. Ronquist,et al.  Nucleoside transport inhibition in ischemic myocardium results in enhanced taurine efflux. , 2001, European journal of pharmacology.

[9]  J. Wernerman,et al.  Insulin(GIK) improves myocardial metabolism in patients during blood cardioplegia. , 2000, Scandinavian cardiovascular journal : SCJ.

[10]  J. Holst,et al.  Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. , 1999, Diabetes care.

[11]  P. MacDonald,et al.  Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. , 1999, Diabetes.

[12]  R. Weisel,et al.  Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia. , 1998, The Journal of thoracic and cardiovascular surgery.

[13]  J. Egan,et al.  GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor. , 1998, American journal of physiology. Cell physiology.

[14]  S. Bloom,et al.  Cardiovascular and pancreatic endocrine responses to glucagon‐like peptide‐1(7–36) amide in the conscious calf , 1997, Experimental physiology.

[15]  M. Caputo,et al.  Effect of ischaemia and reperfusion on the intracellular concentration of taurine and glutamine in the hearts of patients undergoing coronary artery surgery. , 1997, Biochimica et biophysica acta.

[16]  E. Blázquez,et al.  Interactions of exendin-(9–39) with the effects of glucagon-like peptide-1-(7–36) amide and of exendin-4 on arterial blood pressure and heart rate in rats , 1996, Regulatory Peptides.

[17]  J. Habener,et al.  Activation of a cAMP-regulated Ca-Signaling Pathway in Pancreatic -Cells by the Insulinotropic Hormone Glucagon-like Peptide-1 (*) , 1995, The Journal of Biological Chemistry.

[18]  S. Nilsson,et al.  MR Imaging of Gadolinium-DTPA-BMA-Enhanced Reperfused and Nonreperfused Porcine Myocardial Infarction , 1995, Acta radiologica.

[19]  G. Ronquist,et al.  Continuous monitoring of energy metabolites using microdialysis during myocardial ischaemia in the pig. , 1995, European heart journal.

[20]  S. Mojsov,et al.  Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequences , 1995, FEBS letters.

[21]  E. Blázquez,et al.  Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats. , 1994, The American journal of physiology.

[22]  U. Ungerstedt,et al.  Interstitial glucose and lactate balance in human skeletal muscle and adipose tissue studied by microdialysis. , 1993, The Journal of physiology.

[23]  J. Holst,et al.  Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. , 1992, The New England journal of medicine.

[24]  J. Holloszy,et al.  Activation of glucose transport in skeletal muscle by phospholipase C and phorbol ester. Evaluation of the regulatory roles of protein kinase C and calcium. , 1989, The Journal of biological chemistry.

[25]  M. Namba,et al.  Glucagonostatic and Insulinotropic Action of Glucagonlike Peptide I-(7–36)-Amide , 1989, Diabetes.

[26]  S. Bloom,et al.  GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN , 1987, The Lancet.

[27]  J. Lombardini,et al.  Loss of cardiac muscle taurine after acute left ventricular ischemia. , 1977, Life sciences.

[28]  J. Jacobsen,et al.  Biochemistry and physiology of taurine and taurine derivatives. , 1968, Physiological reviews.